Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.

Autor: González-Domínguez I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. irene.gonzalez@mssm.edu., Puente-Massaguer E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Abdeljawad A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lai TY; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Liu Y; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Loganathan M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Francis B; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lemus N; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Dolange V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Boza M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Slamanig S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands., Martínez-Guevara JL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. peter.palese@mssm.edu.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. peter.palese@mssm.edu., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. weina.sun@mssm.edu.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Nov 17; Vol. 9 (1), pp. 222. Date of Electronic Publication: 2024 Nov 17.

Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model

Autor: Rineh, A, Soren, O, McEwan, T, Ravikumar, V, Poh, WH, Azamifar, F, Naimi-Jamal, MR, Cheung, C-Y, Elliott, AG, Zuegg, J, Blaskovich, MAT, Cooper, MA, Dolange, V, Christodoulides, M, Cook, GM, Rice, SA, Faust, SN, Webb, JS, Kelso, MJ

The formation of biofilms provides a formidable defense for many bacteria against antibiotics and host immune responses. As a consequence, biofilms are thought to be the root cause of most chronic infections, including those occurring on medical indw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::ba29ba7d6bf0df2788f19125d1e58314
https://hdl.handle.net/10453/142262

Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model.

Autor: Rineh A; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, New South Wales 2522, Australia., Soren O; Biological Sciences and Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.; National Biofilm Innovation Centre, University of Southampton, Southampton SO17 1BJ, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom., McEwan T; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, New South Wales 2522, Australia., Ravikumar V; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, 637551, Singapore., Poh WH; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, 637551, Singapore., Azamifar F; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia.; Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran., Naimi-Jamal MR; Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran., Cheung CY; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand., Elliott AG; Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia., Zuegg J; Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia., Blaskovich MAT; Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia., Cooper MA; Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia., Dolange V; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom., Christodoulides M; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom., Cook GM; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1042, New Zealand., Rice SA; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, 637551, Singapore.; ithree Institute, University of Technology Sydney, Ultimo, New South Wales 2007, Australia.; School of Biological Sciences, Nanyang Technological University, 637551, Singapore., Faust SN; National Biofilm Innovation Centre, University of Southampton, Southampton SO17 1BJ, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom.; NIHR Southampton Biomedical Research Centre and NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom., Webb JS; Biological Sciences and Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.; National Biofilm Innovation Centre, University of Southampton, Southampton SO17 1BJ, United Kingdom.; NIHR Southampton Biomedical Research Centre and NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom., Kelso MJ; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, New South Wales 2522, Australia.

Publikováno v: ACS infectious diseases [ACS Infect Dis] 2020 Jun 12; Vol. 6 (6), pp. 1460-1479. Date of Electronic Publication: 2020 May 05.

Comparative Efficacy of Parenteral and Mucosal Recombinant Probiotic Vaccines Against SARS-CoV-2 and S. pneumoniae Infections in Animal Models.

Autor: Leontieva, Galina, Kramskaya, Tatiana, Gupalova, Tatiana, Bormotova, Elena, Desheva, Yulia, Korzhevsky, Dmitry, Kirik, Olga, Koroleva, Irina, Borisevitch, Sergey, Suvorov, Alexander

Publikováno v: Vaccines; Oct2024, Vol. 12 Issue 10, p1195, 21p

The Public Health Perspective of Gonococcal Infection in Neonates.

Autor: Balaji, Sivaraman¹, Kamble, Bhushan², Ambalkar, Deepti³, Kundapur, Rashmi², Aggarwal, Sumit¹ aggarwal.sumit@icmr.gov.in

Publikováno v: Indian Journal of Community Medicine. Mar/Apr2023, Vol. 48 Issue 2, p372-374. 3p.